High Tide Announces Preliminary Q3 2026 Guidance

The Company Expects Record Revenue, Gross Profit and Adjusted EBITDA Ahead of Analyst Forecasts

The Company Also Announces Record Quarterly Distribution of Over 10 Tonnes of Medical Cannabis Flower Through Remexian Pharma GmbH, Further Accelerating its German Market Position

CALGARY, AB, Aug. 4, 2026 /PRNewswire/ -- High Tide Inc. ("High Tide" or the "Company") (Nasdaq: HITI) (TSXV: HITI) (FSE: 2LYA), the high-impact, retail-forward enterprise built to deliver real-world value across every component of cannabis, is pleased to release guidance estimates regarding anticipated results for its third fiscal quarter ended July 31, 2026.

High Tide Inc., August 4, 2026